Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Appendiceal neuroendrocrine neoplasms: incidentaloma or something we should worry about?

Lousberg L, Collignon J, Detry O.

Curr Opin Gastroenterol. 2020 Jan;36(1):48-54. doi: 10.1097/MOG.0000000000000597.

PMID:
31633562
2.

Loss of Cubilin, the intrinsic factor-vitamin B12 receptor, impairs visceral endoderm endocytosis and endodermal patterning in the mouse.

Perea-Gomez A, Cases O, Lelièvre V, Pulina MV, Collignon J, Hadjantonakis AK, Kozyraki R.

Sci Rep. 2019 Jul 15;9(1):10168. doi: 10.1038/s41598-019-46559-0.

3.

[Treatment of mucocutaneous toxicity of target therapy in oncology].

Damsin T, Collignon J, Lebas E, Libon F, Dezfoulian B, Nikkels AF.

Rev Med Liege. 2019 Jan;74(1):7-14. French.

4.

Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy.

Foidart P, Yip C, Radermacher J, Blacher S, Lienard M, Montero-Ruiz L, Maquoi E, Montaudon E, Château-Joubert S, Collignon J, Coibion M, Jossa V, Marangoni E, Noël A, Sounni NE, Jerusalem G.

Clin Cancer Res. 2019 Mar 15;25(6):1838-1850. doi: 10.1158/1078-0432.CCR-18-1880. Epub 2018 Nov 30.

PMID:
30504427
5.

WITHDRAWN: A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.

Dumont R, Puleo F, Collignon J, Meurisse N, Chavez M, Seidel L, Gast P, Polus M, Loly C, Delvenne P, Meunier P, Hustinx R, Deroover A, Detry O, Louis E, Martinive P, Van Daele D.

Acta Gastroenterol Belg. 2018 Apr-Jun;81(2):358.

PMID:
30024718
6.

A Requirement for Zic2 in the Regulation of Nodal Expression Underlies the Establishment of Left-Sided Identity.

Dykes IM, Szumska D, Kuncheria L, Puliyadi R, Chen CM, Papanayotou C, Lockstone H, Dubourg C, David V, Schneider JE, Keane TM, Adams DJ, Brown SDM, Mercier S, Odent S, Collignon J, Bhattacharya S.

Sci Rep. 2018 Jul 11;8(1):10439. doi: 10.1038/s41598-018-28714-1.

7.

A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.

Dumont R, Puleo F, Collignon J, Meurisse N, Chavez M, Seidel L, Gast P, Polus M, Loly C, Delvenne P, Meunier P, Hustinx R, Deroover A, Detry O, Louis E, Martinive P, Van Daele D.

Acta Gastroenterol Belg. 2017 Oct-Dec;80(4):451-461. Review. Erratum in: Acta Gastroenterol Belg. 2018 Apr-Jun;81(2):358.

PMID:
29560639
8.

Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.

Wenric S, ElGuendi S, Caberg JH, Bezzaou W, Fasquelle C, Charloteaux B, Karim L, Hennuy B, Frères P, Collignon J, Boukerroucha M, Schroeder H, Olivier F, Jossa V, Jerusalem G, Josse C, Bours V.

Sci Rep. 2017 Dec 12;7(1):17452. doi: 10.1038/s41598-017-17811-2.

9.

Anteroposterior polarity and elongation in the absence of extra-embryonic tissues and of spatially localised signalling in gastruloids: mammalian embryonic organoids.

Turner DA, Girgin M, Alonso-Crisostomo L, Trivedi V, Baillie-Johnson P, Glodowski CR, Hayward PC, Collignon J, Gustavsen C, Serup P, Steventon B, P Lutolf M, Arias AM.

Development. 2017 Nov 1;144(21):3894-3906. doi: 10.1242/dev.150391. Epub 2017 Sep 26.

10.

[Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery].

Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P.

Rev Med Liege. 2017 Apr;72(4):168-174. Review. French.

11.

[Comprehensive therapeutic strategy for localized esophageal cancer].

Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P.

Rev Med Liege. 2017 Feb;72(2):58-63. Review. French.

12.

[Carcinoma of unknown primary : a not so rare entity].

Gonne E, Collignon J, Jerusalem G, Gennigens C.

Rev Med Liege. 2016 Oct;71(10):449-454. Review. French.

13.

MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.

Yip C, Foidart P, Somja J, Truong A, Lienard M, Feyereisen E, Schroeder H, Gofflot S, Donneau AF, Collignon J, Delvenne P, Sounni NE, Jerusalem G, Noël A.

Br J Cancer. 2017 Mar 14;116(6):742-751. doi: 10.1038/bjc.2017.23. Epub 2017 Feb 14.

14.
15.

Triple-negative breast cancer: treatment challenges and solutions.

Collignon J, Lousberg L, Schroeder H, Jerusalem G.

Breast Cancer (Dove Med Press). 2016 May 20;8:93-107. doi: 10.2147/BCTT.S69488. eCollection 2016.

16.

[Biopsy of suspicious lesions in patients with breast cancer].

Colin PE, Schroeder H, Gonne E, Hanocq F, André C, Rorive A, Jerusalem G, Collignon J.

Rev Med Liege. 2015 Nov;70(11):563-8. French.

17.

[CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA].

Van Daele D, Martinive P, Loly C, Polus M, Collignon J, Gast P, Louis E, Van Laethem JL.

Rev Med Liege. 2015 Nov;70(11):540-5. French.

18.

Circulating microRNA-based screening tool for breast cancer.

Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.

Oncotarget. 2016 Feb 2;7(5):5416-28. doi: 10.18632/oncotarget.6786.

19.

NOTCH activation interferes with cell fate specification in the gastrulating mouse embryo.

Souilhol C, Perea-Gomez A, Camus A, Beck-Cormier S, Vandormael-Pournin S, Escande M, Collignon J, Cohen-Tannoudji M.

Development. 2015 Nov 1;142(21):3649-60. doi: 10.1242/dev.121145.

20.

[Evolution in the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma].

Van Daele D, Puleo F, Dumont R, Polus M, Loly C, Martinive P, Meunier P, Collignon J, Hendlisz A, Maréchal R, Louis E, Van Laethem JL.

Rev Med Suisse. 2015 Aug 26;11(483):1543-8. Review. French.

PMID:
26502580
21.

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers.

Boukerroucha M, Josse C, ElGuendi S, Boujemla B, Frères P, Marée R, Wenric S, Segers K, Collignon J, Jerusalem G, Bours V.

BMC Cancer. 2015 Oct 21;15:755. doi: 10.1186/s12885-015-1740-9.

22.

Potential of copper-tolerant grasses to implement phytostabilisation strategies on polluted soils in South D. R. Congo : Poaceae candidates for phytostabilisation.

Boisson S, Le Stradic S, Collignon J, Séleck M, Malaisse F, Ngoy Shutcha M, Faucon MP, Mahy G.

Environ Sci Pollut Res Int. 2016 Jul;23(14):13693-705. doi: 10.1007/s11356-015-5442-2. Epub 2015 Oct 8.

PMID:
26446734
23.

[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].

Jerusalem G, Collignon J, Josse C, Schroeder H, Rorive A, Frères P, Lambert F, Koopmansch B, Poncin A, Bours V.

Rev Med Liege. 2015 May-Jun;70(5-6):269-76. Review. French.

24.

Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer.

Jerusalem G, Rorive A, Collignon J.

Future Oncol. 2015;11(12):1775-89. doi: 10.2217/fon.15.80. Review.

25.

[Management of febrile neutropenia in cancer patients].

Freres P, Gonne E, Collignon J, Giot JB, Gennigens C, Jerusalem G.

Rev Med Liege. 2015 Apr;70(4):195-200. Review. French.

26.

[The drug of the month: everolimus (Afinitor) for the treatment of metastatic breast cancer].

Jerusalem G, Rorive A, Collignon J.

Rev Med Liege. 2014 Sep;69(9):510-7. Review. French.

27.

Activin/Nodal signalling before implantation: setting the stage for embryo patterning.

Papanayotou C, Collignon J.

Philos Trans R Soc Lond B Biol Sci. 2014 Dec 5;369(1657). pii: 20130539. doi: 10.1098/rstb.2013.0539. Review.

28.

EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.

Paye A, Truong A, Yip C, Cimino J, Blacher S, Munaut C, Cataldo D, Foidart JM, Maquoi E, Collignon J, Delvenne P, Jerusalem G, Noel A, Sounni NE.

Cancer Res. 2014 Dec 1;74(23):6758-70. doi: 10.1158/0008-5472.CAN-13-2994. Epub 2014 Oct 15.

29.

A conserved role for non-neural ectoderm cells in early neural development.

Cajal M, Creuzet SE, Papanayotou C, Sabéran-Djoneidi D, Chuva de Sousa Lopes SM, Zwijsen A, Collignon J, Camus A.

Development. 2014 Nov;141(21):4127-38. doi: 10.1242/dev.107425. Epub 2014 Oct 1.

30.

A novel nodal enhancer dependent on pluripotency factors and smad2/3 signaling conditions a regulatory switch during epiblast maturation.

Papanayotou C, Benhaddou A, Camus A, Perea-Gomez A, Jouneau A, Mezger V, Langa F, Ott S, Sabéran-Djoneidi D, Collignon J.

PLoS Biol. 2014 Jun 24;12(6):e1001890. doi: 10.1371/journal.pbio.1001890. eCollection 2014 Jun.

31.

Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.

Jerusalem G, Rorive A, Collignon J.

Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014. Review.

32.

[Radiotherapy for elderly patient with rectal cancer: which benefit?].

Martinive P, Allepaert S, Vandaele D, Polus M, Coimbra C, Kohnen L, Collignon J, Lennerts E, Vanderick J, Coucke P.

Rev Med Liege. 2014;69 Suppl 1:47-52. Review. French.

33.

[Radiotherapy in rectal cancer: when, why and how?].

Martinive P, Vandaele D, Lennerts E, Polus M, Coimbra C, Kohnen L, Vanderick J, Collignon J, Coucke P.

Rev Med Liege. 2014;69 Suppl 1:37-46. Review. French.

34.

A microdevice to locally electroporate embryos with high efficiency and reduced cell damage.

Mazari E, Zhao X, Migeotte I, Collignon J, Gosse C, Perea-Gomez A.

Development. 2014 Jun;141(11):2349-59. doi: 10.1242/dev.106633. Epub 2014 May 12.

35.

Cubilin, a high affinity receptor for fibroblast growth factor 8, is required for cell survival in the developing vertebrate head.

Cases O, Perea-Gomez A, Aguiar DP, Nykjaer A, Amsellem S, Chandellier J, Umbhauer M, Cereghini S, Madsen M, Collignon J, Verroust P, Riou JF, Creuzet SE, Kozyraki R.

J Biol Chem. 2013 Jun 7;288(23):16655-70. doi: 10.1074/jbc.M113.451070. Epub 2013 Apr 16.

36.

[Refusal of application to care in Alzheimer's disease and related diseases: establishment of a mobile unit hospital extra].

Collignon J, Rouch I, Gonthier R, Corbin-Seguin A, Combe L, Trombert-Paviot B, Laurent B, Girtanner C.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Mar;11(1):49-55. doi: 10.1684/pnv.2013.0390. French.

PMID:
23508319
37.

[Will targeted therapies replace chemotherapy?].

Collignon J, Jerusalem G.

Rev Med Liege. 2012;67 Spec No:29-36. French.

38.

Clonal and molecular analysis of the prospective anterior neural boundary in the mouse embryo.

Cajal M, Lawson KA, Hill B, Moreau A, Rao J, Ross A, Collignon J, Camus A.

Development. 2012 Jan;139(2):423-36. doi: 10.1242/dev.075499.

39.

[Methods for establishing a cardiovascular health promotion program in the French section of Belgium].

Coppieters Y, Béduwé C, Collignon JL, Hubens V, Levêque A.

Glob Health Promot. 2011 Sep;18(3):37-46. doi: 10.1177/1757975911412399. French. No abstract available.

PMID:
24803562
40.

[Breast cancer in the elderly patient].

Martin M, Collignon J, Rorive A, André C, Bourhaba M, Allepaerts S, Coucke P, Lifrange E, Jerusalem G.

Rev Med Liege. 2011 May-Jun;66(5-6):400-8. French.

41.

[Breast cancer in young women].

André C, Collignon J, Rorive A, Martin M, Maweja S, Lifrange E, Coucke P, Jerusalem G.

Rev Med Liege. 2011 May-Jun;66(5-6):397-9. French.

42.

[Molecular and genetic aspects of triple negative breast cancer and therapeutic implications].

Collignon J, Struman I, Tabruyn S, Josse C, Boukerroucha M, Jerusalem G, Bours V.

Rev Med Liege. 2011 May-Jun;66(5-6):393-6. French.

43.

[Targeted therapies in breast cancer].

Jerusalem G, Collignon J, Rorive A, Lifrange E, André C, Martin M, Maweja S, Coucke P.

Rev Med Liege. 2011 May-Jun;66(5-6):379-84. French.

44.

[Systemic chemotherapy and breast cancer].

Collignon J, Rorive A, Martin M, Andre C, Maweja S, Lifrange E, Coucke P, Jerusalem G.

Rev Med Liege. 2011 May-Jun;66(5-6):372-8. French.

45.

[Hormone therapy for breast cancer].

Lifrange E, Andre C, Bleret V, Collignon J, Coucke P, Cusumano P, Desreux J, Herman P, Jerusalem G, Kridelka F, Martin M, Rorive A, Van Cauwenberge JR, Colin C.

Rev Med Liege. 2011 May-Jun;66(5-6):367-71. French.

46.

[Radiotherapy in breast cancer: current standards of treatment, prediction of local recurrence and open questions].

Coucke P, Lakosi F, Rorive A, Janvary ZL, Collignon J, Jansen N, Andre C, Jerusalem G.

Rev Med Liege. 2011 May-Jun;66(5-6):320-5. French.

47.

[Late relapse of breast cancer after adjuvant chemotherapy].

Lousberg L, Somja J, Collignon J, Gilles C, Jerusalem G.

Rev Med Liege. 2011 May-Jun;66(5-6):306-10. French.

48.

[Breast cancer and brain metastases].

Rorive A, Collignon J, Martin M, André C, Jerusalem G, Coucke P.

Rev Med Liege. 2011 May-Jun;66(5-6):299-305. French.

49.

[Imaging bone metastases in breast cancer].

Withofs N, Collignon J, Hustinx R.

Rev Med Liege. 2011 May-Jun;66(5-6):291-8. French.

50.

[Heterogeneity of bone metastases in a patient with breast cancer: case report illustrating the potential of combining various imaging techniques].

Withofs N, Collignon J, Rorive A, Jerusalem G, Hustinx R.

Rev Med Liege. 2011 May-Jun;66(5-6):288-90. French.

Supplemental Content

Loading ...
Support Center